Stockscreener 앱 받기
67.85
1.60%
1.07
시간 외 거래:
67.85
전일 마감가:
$66.78
열려 있는:
$66.975
하루 거래량:
9.93M
Relative Volume:
0.99
시가총액:
$87.86B
수익:
$378.96B
순이익/손실:
$5.28B
주가수익비율:
16.19
EPS:
4.19
순현금흐름:
$5.94B
1주 성능:
-2.30%
1개월 성능:
+0.33%
6개월 성능:
+22.16%
1년 성능:
+23.57%
1일 변동 폭
$66.53
$68.52
1주일 범위
$65.84
$70.30
52주 변동 폭
$43.56
$72.51
CVS헬스 Stock (CVS) Company Profile
명칭
Cvs Health Corp
전화
(401) 765-1500
주소
ONE CVS DR., WOONSOCKET
CVS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
67.85 | 87.86B | 378.96B | 5.28B | 5.94B | 4.19 |
|
UNH
Unitedhealth Group Inc
|
385.55 | 548.34B | 410.06B | 22.11B | 24.86B | 23.88 |
|
ELV
Elevance Health Inc
|
412.38 | 92.25B | 183.12B | 5.92B | 3.67B | 25.63 |
|
CI
Cigna Group
|
333.11 | 89.54B | 254.47B | 5.03B | 6.01B | 18.06 |
|
HUM
Humana Inc
|
253.35 | 30.90B | 117.76B | 1.21B | 2.39B | 9.95 |
CVS헬스 Stock (CVS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-13 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | 업그레이드 | Edward Jones | Hold → Buy |
| 2024-12-03 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-11-18 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2024-10-04 | 업그레이드 | TD Cowen | Hold → Buy |
| 2024-05-30 | 개시 | Robert W. Baird | Neutral |
| 2024-05-07 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2024-05-02 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-05-01 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | 개시 | Barclays | Equal Weight |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2023-12-22 | 개시 | HSBC Securities | Buy |
| 2023-09-19 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-09-12 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | 다운그레이드 | Edward Jones | Buy → Hold |
| 2023-05-26 | 개시 | Piper Sandler | Overweight |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-11-23 | 재개 | Morgan Stanley | Overweight |
| 2022-06-17 | 개시 | Loop Capital | Buy |
| 2022-05-27 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-02-11 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | 개시 | Goldman | Buy |
| 2021-12-01 | 개시 | Seaport Research Partners | Buy |
| 2021-05-19 | 개시 | Wells Fargo | Equal Weight |
| 2021-03-17 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-01-08 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-09-17 | 개시 | Piper Sandler | Overweight |
| 2020-07-01 | 개시 | SVB Leerink | Mkt Perform |
| 2020-05-14 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | 재개 | RBC Capital Mkts | Outperform |
| 2019-09-12 | 개시 | Deutsche Bank | Buy |
| 2019-06-05 | 업그레이드 | Standpoint Research | Hold → Buy |
| 2019-04-29 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | 개시 | Guggenheim | Buy |
| 2019-04-15 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2019-04-10 | 재확인 | BofA/Merrill | Buy |
| 2019-03-13 | 개시 | Bernstein | Outperform |
| 2019-02-20 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | 개시 | UBS | Buy |
| 2018-12-18 | 개시 | Barclays | Overweight |
| 2018-11-29 | 재개 | Goldman | Neutral |
| 2018-11-28 | 개시 | Evercore ISI | Outperform |
| 2018-10-26 | 재개 | Wolfe Research | Peer Perform |
| 2018-07-09 | 업그레이드 | Citigroup | Neutral → Buy |
| 2018-02-27 | 재개 | BofA/Merrill | Buy |
| 2018-02-13 | 재확인 | Citigroup | Neutral |
모두보기
CVS헬스 주식(CVS)의 최신 뉴스
AG alleges CVS didn’t share discounts with MassHealth members - The Boston Globe
AM Best Affirms Credit Ratings of CVS Health Corporation’s Aetna Inc. Subsidiaries - Stock Titan
FY2025 EPS Forecast for CVS Health Increased by Analyst - MarketBeat
Cantor Fitzgerald maintains CVS Health stock at Overweight By Investing.com - Investing.com Nigeria
CVS Hid Prescription Discounts From Medicaid, States Allege - Law360
AG Campbell sues CVS for allegedly overcharging MassHealth for prescriptions - WWLP
JPMorgan raises CVS Health stock target to $86, keeps Overweight rating - Investing.com
CVS Can Arbitrate Clinic Worker's Suit Alleging Illegal Layoffs - Law360
Stocktwits Spotlight: NRx, CVS, ReShape Lead Weekly Jump In Health Care Stock Chatter - MSN
Jim Cramer on CVS Health Corporation (CVS): ‘David Joyner’s Stunning Turnaround Continues’ - Insider Monkey
Glenview Capital Reduces Stake in CVS (CVS) Post Strong Earnings - GuruFocus
Leerink Partnrs Has Weak Estimate for CVS Health Q2 Earnings - MarketBeat
Activist Glenview cuts stake in CVS after strong first-quarter earnings - Reuters
CVS Achieves 25% Return Amid Turnaround Efforts | CVS Stock News - GuruFocus
Activist investor Glenview Capital reduces stake in CVS Health By Reuters - Investing.com
Activist Investor Glenview Capital Reduces Stake in CVS Health - US News Money
Glenviw issues statement on CVS Health - TipRanks
CVS’s ‘Healthy’ Results Prompts Activist Glenview to Pare Stake - Bloomberg.com
Glenview Capital Reveals How New CVS Leadership Delivered 25% Returns in Just 12 Months - Stock Titan
Cantor Fitzgerald maintains CVS Health stock at Overweight - Investing.com
CVS Health (CVS) Sees Price Target Upgrade by Wells Fargo | CVS Stock News - GuruFocus
CVS Health (CVS) Target Price Boosted by Wells Fargo Amid Perfor - GuruFocus
CVS Health’s SWOT analysis: stock poised for growth amid challenges - Investing.com
CVS Health Corporation (CVS): Among the Best Performing Large Cap Stocks So Far in 2025 - Insider Monkey
RBC Capital Boosts Price Target for CVS to $81 Following Q1 Resu - GuruFocus
CVS (CVS) Embarks on Strategic Shift Amidst Health Sector Challe - GuruFocus
RBC Capital Raises Price Target for CVS Health to $81 | CVS Stock News - GuruFocus
RBC Capital Boosts Price Target for CVS to $81 Following Q1 Results | CVS Stock News - GuruFocus
CVS Health (CVS) Price Target Boosted by Analyst Following Positive Outlook | CVS Stock News - GuruFocus
Comerica Bank Reduces Stock Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS (CVS) Embarks on Strategic Shift Amidst Health Sector Challenges - GuruFocus
2 Healthcare Stocks to Research Further and 1 to Be Wary Of - The Globe and Mail
One68 Global Capital LLC Buys Shares of 80,597 CVS Health Co. (NYSE:CVS) - MarketBeat
8 Knots Management LLC Decreases Stock Position in CVS Health Co. (NYSE:CVS) - MarketBeat
Is CVS Health Corporation (CVS) The Best Stock To Buy and Hold For 10 Years? - Insider Monkey
CVS Health (CVS) Exceeds Earnings Expectations, Analysts Maintain Revenue Forecasts - GuruFocus
What is CVS? 'We are ... working through that very question' - Yahoo
CVS Health rides improving Medicare business to better-than-expected first quarter - LancasterOnline
Northern Trust Corp Acquires 928,833 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health (CVS) Exceeds Q1 Expectations with Revenue and EPS Gains - GuruFocus
12 Best Stocks to Buy and Hold For 10 Years - Insider Monkey
CVS Health Corporation (NYSE:CVS) Q1 2025 Earnings Call Transcript - Insider Monkey
Whitebox Advisors LLC Acquires New Shares in CVS Health Co. (NYSE:CVS) - MarketBeat
Freestone Grove Partners LP Buys Shares of 806,575 CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Rides Improving Medicare Business In First Quarter - Post Journal
UBS Raises Price Target for CVS Health (CVS) to $71 | CVS Stock News - GuruFocus
CVS Health Stock Price | CVS Stock Quote, News, and History - markets.businessinsider.com
A Glimpse Into The Expert Outlook On CVS Health Through 10 Analysts - Benzinga
CVS (CVS) Shows Resilience with Solid Earnings Amid Healthcare Shifts - GuruFocus
CVS makes deal to make popular weight loss drug cheaper - TheStreet
CVS Health Raises Forecast After Strong Q1 Results - Finimize
CVS헬스 (CVS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.40%
0.09%
자본화:
|
볼륨(24시간):